Allogene Therapeutics Inc (NAS:ALLO)
$ 2.14 -0.05 (-2.28%) Market Cap: 459.18 Mil Enterprise Value: 269.53 Mil PE Ratio: 0 PB Ratio: 0.99 GF Score: 37/100

Q1 2024 Allogene Therapeutics Inc Earnings Call Transcript

May 13, 2024 / 09:00PM GMT
Release Date Price: $2.9 (+5.07%)
Operator

Hello, and welcome to the Allogene Therapeutics first quarter 2024 conference call. (Operator Instructions) Please be aware that today's conference is being recorded. We ask that you limit yourself to one question only.

I would now like to turn the conference over to Christine Cassiano, Chief Corporate Affairs and Brand Strategy Officer. You may begin.

Christine Cassiano
Allogene Therapeutics Inc - EVP, Chief Corporate Affairs and Brand Strategy Officer

Thank you, operator, and welcome to all who have joined this call after the market closed today, Allogene issued a press release that provides a business update and financial results for the first quarter of 2024. This press release and today's webcast are both available on our website. Following our prepared remarks, we will host a Q&A session. We ask you to limit your questions to one per person as we will keep this call to an hour and do our best to get to as many questions as possible.

Joining me today are Dr. David Chang, President and Chief Executive Officer; Dr. Zachary Roberts,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot